Oklahoma health and medical news briefs

Health and medical news briefs for Nov. 25
Oklahoman Published: November 25, 2012

About 23,000 Americans are diagnosed with a malignant glioma each year and more than 13,000 will die, according to the American Cancer Society. A new discovery by OMRF researchers Rheal Towner and Jonathan Wren might help surgeons minimize collateral damage in surgery.

The researchers identified a gene called ELTD1, which can serve as a new “biomarker” — a way to identify the cancerous cells. By using this gene as a mapping tool, surgeons could treat tumors while leaving more healthy brain tissue intact. The gene could be useful for early diagnosis of brain cancers and might help doctors plan more effective treatments — all important factors for increasing patients' odds of survival, researchers said.

FROM STAFF REPORTS